This issue of News & Views will focus on new developments in contrast media agents, low molecular weight heparin, and glycoprotein (GP) Hb/IIIa inhibitors used in the treatment of acute and chronic coronary artery disease, and optimal anticoagulation therapy after placement of an intracoronary stent.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً